X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 2026-02-17 | HTGC | Hercules Capital, Inc. | Closed-End Funds | 3 | P - Purchase | $15.46 | +56,165 | 2,654,450 | +2% | +$868,208 | |||||
| 4 D | 2026-02-20 | HLNE | Hamilton Lane Inc | Investment Advice | 4 | P - Purchase | $107.25 | +30,000 | 3,856,020 | +1% | +$3,217,592 | |||||
| 5 | 2026-02-23 | AVBC | Avidia Bancorp, Inc. | Savings Institutions, Not Federally Chartered | 4 | P - Purchase | $16.95 | +18,312 | 222,472 | +9% | +$310,415 | |||||
| 3 | 2026-02-23 | CEVA | Ceva Inc | Computer Programming, Data Processing, Etc. | 3 | P - Purchase | $19.52 | +8,910 | 466,173 | +2% | +$173,907 | |||||
| 4 | 2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Surgical & Medical Instruments & Apparatus | 4 | P - Purchase | $4.10 | +431,828 | 1,800,362 | +32% | +$1,770,496 | |||||
| 4 M | 2026-02-19 | SWZ | Total Return Securities Fund | Closed-End Funds | 2 | P - Purchase | $6.02 | +44,000 | 132,366 | +50% | +$264,825 | |||||
| 2 D | 2026-02-03 | PMN | Promis Neurosciences Inc. | Pharmaceutical Preparations | 2 | P - Purchase | $12.14 | +702,370 | 947,031 | +287% | +$8,524,993 | |||||
| 2 | 2026-02-20 | PODD | Insulet Corp | Surgical & Medical Instruments & Apparatus | 2 | P - Purchase | $252.58 | +5,262 | 18,511 | +40% | +$1,329,089 | |||||
| 2 | 2025-12-05 | MSCI | Msci Inc. | Business Services | 2 | P - Purchase | $537.75 | +16,181 | 2,200,903 | +1% | +$8,701,288 | |||||
| 4 | 2026-02-13 | QDEL | Quidelortho Corp | In Vitro & In Vivo Diagnostic Substances | 3 | P - Purchase | $23.74 | +27,280 | 199,467 | +16% | +$647,731 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-23 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.47 | +100,000 | 51,658,909 | 0% | +$147,000 | ||||||
| D | 2026-02-20 | CAR | Avis Budget Group, Inc. | Pentwater Capital Management LP | 10% | P - Purchase | $94.26 | +425,000 | 8,059,400 | +6% | +$40,060,075 | |||||
2026-02-24 | UBER | Uber Technologies, Inc | Krishnamurthy Balaji (A) | CFO | P - Purchase | $71.25 | +22,453 | 28,742 | +357% | +$1,599,780 | ||||||
2026-02-24 | HTGC | Hercules Capital, Inc. | Bluestein Scott | CEO | P - Purchase | $15.08 | +30,000 | 2,509,379 | +1% | +$452,400 | ||||||
2026-02-20 | ARES | Ares Management Corp | Olian Judy D. | Dir | P - Purchase | $124.43 | +480 | 29,734 | +2% | +$59,726 | ||||||
2026-02-20 | NP | Neptune Insurance Holdings Inc. | Vostrizansky Michael Warren | Dir | P - Purchase | $21.50 | +23,000 | 23,000 | New | +$494,415 | ||||||
2026-02-20 | OCUL | Ocular Therapeutix, Inc | Lindstrom Richard L Md | Dir | P - Purchase | $7.66 | +60,229 | 246,933 | +32% | +$461,354 | ||||||
| M | 2026-02-20 | FIG | Figma, Inc. | Reed Andrew Phillips | Dir | P - Purchase | $24.91 | +1,466,852 | 34,004,169 | +5% | +$36,537,073 | |||||
| M | 2026-02-20 | ACOG | Alpha Cognition Inc. | Opaleye Management Inc. | 10% | P - Purchase | $5.86 | +171,410 | 2,364,410 | +8% | +$1,003,958 | |||||
2026-02-24 | EIG | Employers Holdings, Inc. | Pedraja Michael | EVP, CFO | P - Purchase | $39.73 | +2,000 | 19,830 | +11% | +$79,460 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-23 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.47 | +100,000 | 51,658,909 | 0% | +$147,000 | ||||||
2026-02-23 | TBI | Trueblue, Inc. | Schweihs Carl | EVP, CFO | P - Purchase | $3.72 | +12,500 | 289,069 | +5% | +$46,500 | ||||||
| M | 2026-02-20 | UUU | Universal Safety Products, Inc. | Ault Milton C III | Dir, 10% | P - Purchase | $4.77 | +14,306 | 492,963 | +3% | +$68,269 | |||||
2026-02-20 | CNDT | Conduent Inc | Agadi Harshavardhan V | CEO | P - Purchase | $1.56 | +117,099 | 2,233,928 | +6% | +$182,909 | ||||||
2026-02-20 | ARAY | Accuray Inc | Mayer Steven F | Dir | P - Purchase | $0.56 | +54,875 | 1,545,620 | +4% | +$30,878 | ||||||
2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Gordon Gary B. | Dir | P - Purchase | $4.10 | +9,756 | 9,756 | New | +$40,000 | ||||||
2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Valle William | Dir | P - Purchase | $4.10 | +30,487 | 30,487 | New | +$124,997 | ||||||
2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $4.10 | +30,487 | 773,289 | +4% | +$124,997 | ||||||
2026-02-23 | TLSI | Trisalus Life Sciences, Inc. | Stansky Michael P | Dir | P - Purchase | $4.10 | +361,098 | 986,830 | +58% | +$1,480,502 | ||||||
| M | 2026-02-19 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.47 | +150,000 | 51,558,909 | 0% | +$219,755 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-24 | YUMC | Yum China Holdings, Inc. | Lu Xueling | Controller, PAO | S - Sale+OE | $55.84 | -23,504 | 9,042 | -72% | -$1,312,404 | |||||
| M | 2026-02-23 | PCOR | Procore Technologies, Inc. | Singer Benjamin C | GC; Secretary | S - Sale | $50.16 | -6,938 | 64,660 | -10% | -$348,023 | |||||
| M | 2026-02-20 | PLTR | Palantir Technologies Inc. | Buckley Jeffrey | See Remarks | S - Sale | $132.27 | -3,936 | 43,108 | -8% | -$520,601 | |||||
2026-02-20 | PLTR | Palantir Technologies Inc. | Taylor Ryan D. | See Remarks | S - Sale | $133.72 | -19,988 | 219,421 | -8% | -$2,672,765 | ||||||
2026-02-20 | PLTR | Palantir Technologies Inc. | Glazer David A. | See Remarks | S - Sale | $133.72 | -17,438 | 392,370 | -4% | -$2,331,782 | ||||||
| D | 2026-02-20 | PLTR | Palantir Technologies Inc. | Sankar Shyam | See Remarks | S - Sale+OE | $133.72 | -168,004 | 1,392,685 | -11% | -$22,465,231 | |||||
| D | 2026-02-20 | PLTR | Palantir Technologies Inc. | Cohen Stephen Andrew | See Remarks | S - Sale+OE | $133.72 | -327,088 | 592 | -100% | -$43,737,696 | |||||
| D | 2026-02-20 | PLTR | Palantir Technologies Inc. | Karp Alexander C. | See Remarks | S - Sale+OE | $133.78 | -493,025 | 6,432,258 | -7% | -$65,955,988 | |||||
| D | 2026-02-23 | IBRX | Immunitybio, Inc. | Selecky Christobel | Dir | S - Sale+OE | $10.00 | -25,000 | 0 | -100% | -$250,000 | |||||
| DM | 2026-02-20 | IBRX | Immunitybio, Inc. | Simon Barry J. | Dir | S - Sale+OE | $10.19 | -175,000 | 2,925,821 | -6% | -$1,783,602 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-23 | BRO | Brown & Brown, Inc. | Boyd Stephen M | EVP, Pres Spec Dist Segment | F - Tax | $69.59 | -7,712 | 127,535 | -6% | -$536,678 | ||||||
2026-02-23 | BRO | Brown & Brown, Inc. | Turpin Julie | EVP, Chief People Officer | F - Tax | $69.59 | -4,418 | 68,305 | -6% | -$307,449 | ||||||
2026-02-23 | BRO | Brown & Brown, Inc. | Brown J Powell | Pres, CEO | F - Tax | $69.59 | -44,737 | 2,345,954 | -2% | -$3,113,248 | ||||||
2026-02-23 | BRO | Brown & Brown, Inc. | Penny Jerome Scott | EVP Chief Acquisitions Officer | F - Tax | $69.59 | -7,058 | 696,349 | -1% | -$491,166 | ||||||
2026-02-23 | BRO | Brown & Brown, Inc. | Walker Chris L | EVP, Chair Spec Dist Segment | F - Tax | $69.59 | -3,031 | 212,261 | -1% | -$210,927 | ||||||
2026-02-23 | BRO | Brown & Brown, Inc. | Brown P Barrett | EVP | F - Tax | $69.59 | -8,440 | 3,250,497 | 0% | -$587,340 | ||||||
2026-02-23 | BRO | Brown & Brown, Inc. | Watts R. Andrew | EVP, CFO, Treasurer | F - Tax | $69.59 | -11,646 | 180,308 | -6% | -$810,445 | ||||||
2026-02-23 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.47 | +100,000 | 51,658,909 | 0% | +$147,000 | ||||||
| D | 2026-02-24 | YUMC | Yum China Holdings, Inc. | Lu Xueling | Controller, PAO | M - OptEx | $26.56 | +3,726 | 9,042 | +70% | +$98,963 | |||||
| D | 2026-02-24 | YUMC | Yum China Holdings, Inc. | Lu Xueling | Controller, PAO | D - Sale to issuer | $55.97 | -1,769 | 9,042 | -16% | -$99,011 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |